CRBU

Caribou Biosciences (CRBU)

Caribou Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CRBU

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/01/20	19 : 45	PR Newswire (US)	Caribou Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - CRBU	NASDAQ:CRBU	Caribou Biosciences Inc
2025/01/16	19 : 45	PR Newswire (US)	CRBU LAWSUIT ALERT: The Gross Law Firm Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	NASDAQ:CRBU	Caribou Biosciences Inc
2025/01/13	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRBU	Caribou Biosciences Inc
2025/01/13	19 : 45	PR Newswire (US)	Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBU	NASDAQ:CRBU	Caribou Biosciences Inc
2025/01/13	09 : 05	GlobeNewswire Inc.	Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025	NASDAQ:CRBU	Caribou Biosciences Inc
2025/01/11	07 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2025/01/11	06 : 55	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2025/01/09	19 : 45	PR Newswire (US)	Class Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact The Gross Law Firm	NASDAQ:CRBU	Caribou Biosciences Inc
2025/01/08	06 : 00	GlobeNewswire Inc.	Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:CRBU	Caribou Biosciences Inc
2025/01/06	19 : 45	PR Newswire (US)	The Gross Law Firm Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBU	NASDAQ:CRBU	Caribou Biosciences Inc
2025/01/03	02 : 50	PR Newswire (US)	Class Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact The Gross Law Firm	NASDAQ:CRBU	Caribou Biosciences Inc
2025/01/02	22 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRBU	Caribou Biosciences Inc
2025/01/02	22 : 00	GlobeNewswire Inc.	Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer	NASDAQ:CRBU	Caribou Biosciences Inc
2024/12/07	06 : 06	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:CRBU	Caribou Biosciences Inc
2024/11/23	06 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/11/21	06 : 00	GlobeNewswire Inc.	Caribou Biosciences to Participate in Upcoming Investor Conferences	NASDAQ:CRBU	Caribou Biosciences Inc
2024/11/15	08 : 08	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:CRBU	Caribou Biosciences Inc
2024/11/07	06 : 08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CRBU	Caribou Biosciences Inc
2024/11/07	06 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRBU	Caribou Biosciences Inc
2024/11/07	06 : 05	GlobeNewswire Inc.	Caribou Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update	NASDAQ:CRBU	Caribou Biosciences Inc
2024/10/05	05 : 02	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/09/28	05 : 02	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:CRBU	Caribou Biosciences Inc
2024/09/25	22 : 00	GlobeNewswire Inc.	Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024	NASDAQ:CRBU	Caribou Biosciences Inc
2024/09/04	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRBU	Caribou Biosciences Inc
2024/09/03	21 : 00	GlobeNewswire Inc.	Caribou Biosciences Announces the FDA has Granted Fast Track Designations to CB-010 in Refractory SLE and to CB-012 in Relapsed or Refractory AML	NASDAQ:CRBU	Caribou Biosciences Inc
2024/08/27	05 : 00	GlobeNewswire Inc.	Caribou Biosciences to Participate in Upcoming Investor Conferences	NASDAQ:CRBU	Caribou Biosciences Inc
2024/08/21	05 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/08/21	05 : 05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/08/12	21 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRBU	Caribou Biosciences Inc
2024/08/12	21 : 00	GlobeNewswire Inc.	Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer	NASDAQ:CRBU	Caribou Biosciences Inc